GANDHY VAN MEETEREN: Open Payments
NPI 1053636274 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,733 in 105 payments from 22 companies in 2025. Trend: 2023 $1,515 · 2024 $2,597 · 2025 $2,733
Food & beverage: $2,733
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $787 |
| Eisai Inc. | 9 | $239 |
| Merz Pharmaceuticals, LLC | 5 | $219 |
| UCB, Inc. | 6 | $213 |
| Alexion Pharmaceuticals, Inc. | 4 | $200 |
| Neurocrine BioSciences, Inc. | 8 | $159 |
| Neurelis, Inc. | 9 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $130 |
| Teva Pharmaceuticals USA, Inc. | 2 | $125 |
| ACADIA Pharmaceuticals Inc | 1 | $115 |
Products named: QULIPTA, UBRELVY, Leqembi, ULTOMIRIS, INBRIJA, BOTOX, INGREZZA, Nayzilam.
Industry payments across FL — which companies pay providers there.
